Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study

OBJECTIVE: Treatment of severe ulcerative colitis (UC) is challenging. Although the efficacy of tacrolimus (TAC) and infliximab (IFX) have been evaluated in patients with severe UC, the safety and efficacy levels of sequential therapies (TAC→IFX/IFX→TAC) in these patients remain unclear. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Minami, Naoki, Yoshino, Takuya, Matsuura, Minoru, Koshikawa, Yorimitsu, Yamada, Satoshi, Toyonaga, Takahiko, Madian, Ali, Honzawa, Yusuke, Nakase, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599165/
https://www.ncbi.nlm.nih.gov/pubmed/26462273
http://dx.doi.org/10.1136/bmjgast-2014-000021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599165/
https://www.ncbi.nlm.nih.gov/pubmed/26462273
http://dx.doi.org/10.1136/bmjgast-2014-000021

Ejemplares similares